TY - JOUR
T1 - Intraluminal pressure stimulates MAP kinase phosphorylation in arterioles
T2 - temporal dissociation from myogenic contractile response.
AU - Spurrell, Brian
AU - Murphy, Timothy
AU - Hill, Micheal
N1 - Imported on 12 Apr 2017 - DigiTool details were: month (773h) = October, 2003; Journal title (773t) = American Journal of Physiology: Heart and Circulatory Physiology. ISSNs: 0363-6135;
PY - 2003/10
Y1 - 2003/10
N2 - Members of the MAPK family of enzymes, p42/44 and p38, have been implicated in both the regulation of contractile function and growth responses in vascular smooth muscle. We determined whether such kinases are activated during the arteriolar myogenic response after increases in intraluminal pressure. Particular emphasis was placed on temporal aspects of activation to determine whether such phosphorylation events parallel the known time course for myogenic contraction. Experiments used single cannulated arterioles isolated from the cremaster muscle of rats with some vessels loaded with the fluorescent Ca2+-sensitive dye fura 2 (2 microM). The p42/44 inhibitor PD-98059 (50 microM) caused vasodilation but did not prevent pressure-induced myogenic constriction. The vasodilator response was accompanied by decreased smooth muscle intracellular Ca2+. Western blotting revealed a significant increase in the level of phosphorylation of p42/44 15 min after the application of a 30- to 100-mmHg pressure step. Phosphorylation of p42/44 was a late event that appeared to be temporally dissociated from contraction, which was complete within 1-5 min. EGF (80 nM) caused marked phosphorylation of p42/44 but only acted as a weak vasoconstrictor. The p38 inhibitor SB-203580 (10 microM) did not alter baseline diameter, nor did it prevent myogenic vasoconstriction. Consistent with these observations, SB-203580 did not cause a measurable change in intracellular Ca2+. The results demonstrate activation of the p42/44 class of MAPK resulting from increased transmural pressure. Such activation is, however, dissociated from the acute pressure-induced vasoconstrictor response in terms of time course and may represent the activation of compensatory, but parallel, pathways, including those related to growth and remodeling.
AB - Members of the MAPK family of enzymes, p42/44 and p38, have been implicated in both the regulation of contractile function and growth responses in vascular smooth muscle. We determined whether such kinases are activated during the arteriolar myogenic response after increases in intraluminal pressure. Particular emphasis was placed on temporal aspects of activation to determine whether such phosphorylation events parallel the known time course for myogenic contraction. Experiments used single cannulated arterioles isolated from the cremaster muscle of rats with some vessels loaded with the fluorescent Ca2+-sensitive dye fura 2 (2 microM). The p42/44 inhibitor PD-98059 (50 microM) caused vasodilation but did not prevent pressure-induced myogenic constriction. The vasodilator response was accompanied by decreased smooth muscle intracellular Ca2+. Western blotting revealed a significant increase in the level of phosphorylation of p42/44 15 min after the application of a 30- to 100-mmHg pressure step. Phosphorylation of p42/44 was a late event that appeared to be temporally dissociated from contraction, which was complete within 1-5 min. EGF (80 nM) caused marked phosphorylation of p42/44 but only acted as a weak vasoconstrictor. The p38 inhibitor SB-203580 (10 microM) did not alter baseline diameter, nor did it prevent myogenic vasoconstriction. Consistent with these observations, SB-203580 did not cause a measurable change in intracellular Ca2+. The results demonstrate activation of the p42/44 class of MAPK resulting from increased transmural pressure. Such activation is, however, dissociated from the acute pressure-induced vasoconstrictor response in terms of time course and may represent the activation of compensatory, but parallel, pathways, including those related to growth and remodeling.
KW - Adenosine/pharmacology
KW - Animals
KW - Arterioles/metabolism
KW - Cyclooxygenase Inhibitors/pharmacology
KW - Electrophoresis
KW - Endothelium
KW - Enzyme Inhibitors/pharmacology
KW - Epidermal Growth Factor/pharmacology
KW - Flavonoids/pharmacology
KW - Imidazoles/pharmacology
KW - Indomethacin/pharmacology
KW - Male
KW - Mitogen-Activated Protein Kinases/metabolism
KW - Muscle
KW - Phosphorylation/drug effects
KW - Polyacrylamide Gel
KW - Pressure
KW - Pyridines/pharmacology
KW - Rats
KW - Smooth
KW - Sprague-Dawley
KW - Time Factors
KW - Vascular/cytology/enzymology
KW - Vascular/physiology
KW - Vasoconstriction/physiology
KW - Vasomotor System/drug effects
M3 - Article
SN - 0363-6135
VL - 285
SP - H1764-H1773
JO - American Journal of Physiology - Heart and Circulatory Physiology
JF - American Journal of Physiology - Heart and Circulatory Physiology
IS - 4
ER -